| 注册
首页|期刊导航|中国药房|基本药物目录地方增补品种模式的利弊分析及对策研究

基本药物目录地方增补品种模式的利弊分析及对策研究

孙利华 王长之 孙晓燕

中国药房2011,Vol.22Issue(36):3361-3364,4.
中国药房2011,Vol.22Issue(36):3361-3364,4.

基本药物目录地方增补品种模式的利弊分析及对策研究

Analysis of Advantages and Disadvantages of the Mode of Local Additional Varieties of Essential Drug List and Its Relevant Countermeasures

孙利华 1王长之 1孙晓燕2

作者信息

  • 1. 沈阳药科大学工商管理学院,沈阳市110016
  • 2. 烟台鲁银药业有限公司,烟台市264002
  • 折叠

摘要

Abstract

OBJECTIVE: To provide the references for selecting the mode of the development of essential drug list which is consistent with the current conditions of China. METHODS: Based on the study of national policies and relevant documents, the advantage and disadvantage of the current mode of local additional varieties of the essential drug list were analyzed through the method of summary and logical reasoning. RESULTS & CONCLUSION: The mode of local additional varieties of essential drug list apparently has more disadvantages than advantages, which is not fit for national conditions in China. Our country should adopt the mode of multi-species without addition to develop essential drug list.

关键词

基本药物/基本药物目录/增补品种

Key words

Essential drugs/ Essential drug list/ Additional species

分类

医药卫生

引用本文复制引用

孙利华,王长之,孙晓燕..基本药物目录地方增补品种模式的利弊分析及对策研究[J].中国药房,2011,22(36):3361-3364,4.

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文